Absorica LD is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Isotretinoin.
Product ID | 10631-002_2624e8da-e473-4136-b6c6-a59b6cc14d01 |
NDC | 10631-002 |
Product Type | Human Prescription Drug |
Proprietary Name | Absorica LD |
Generic Name | Isotretinoin |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2019-11-20 |
Marketing Category | NDA / NDA |
Application Number | NDA211913 |
Labeler Name | Sun Pharmaceutical Industries, Inc. |
Substance Name | ISOTRETINOIN |
Active Ingredient Strength | 8 mg/1 |
Pharm Classes | Retinoid [EPC],Retinoids [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-11-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA211913 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-11-20 |
Ingredient | Strength |
---|---|
ISOTRETINOIN | 8 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
10631-005 | Absorica LD | Absorica LD |
10631-006 | Absorica LD | Absorica LD |
10631-002 | Absorica LD | Absorica LD |
10631-003 | Absorica LD | Absorica LD |
10631-007 | Absorica LD | Absorica LD |
10631-004 | Absorica LD | Absorica LD |
0378-6611 | Amnesteem | isotretinoin |
0378-6612 | Amnesteem | isotretinoin |
0378-6614 | Amnesteem | isotretinoin |
0555-1054 | Claravis | Isotretinoin |
0555-1055 | Claravis | Isotretinoin |
0555-1056 | Claravis | Isotretinoin |
0555-1057 | Claravis | Isotretinoin |
0245-0570 | Isotretinoin | Isotretinoin |
0245-0571 | Isotretinoin | Isotretinoin |
0245-0573 | Isotretinoin | Isotretinoin |
0245-0575 | Isotretinoin | Isotretinoin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ABSORICA LD 88802710 not registered Live/Pending |
Sun Pharmaceutical Industries, Inc. 2020-02-19 |
ABSORICA LD 88173525 not registered Live/Pending |
Sun Pharmaceutical Industries, Inc. 2018-10-29 |